Savara (SVRA) Interest Expenses (2011 - 2026)

Savara's (SVRA) quarterly Interest Expenses came in at $617000.0 in Q1 2026, down 53.43% year-on-year from $1.3 million in Q1 2025, and up 126.04% on a QoQ basis from -$2.4 million in Q4 2025.

Savara (SVRA) Interest Expenses (2011 - 2026) Analysis & Trends

Savara (SVRA) has 16 years of Interest Expenses data on file, last reported at $617000.0 in Q1 2026.

  • On a quarterly basis, Interest Expenses fell 53.43% year-over-year to $617000.0 in Q1 2026; TTM through Mar 2026 was $78000.0, a 97.31% decrease from a year earlier, with the FY2025 full-year figure at $142.7 million, up 32.95% from the prior year.
  • Interest Expenses for Q1 2026 stood at $617000.0, up from -$2.4 million in the prior quarter.
  • Over the last five years, Interest Expenses for SVRA reached as high as $1.3 million in Q1 2025 and fell as low as -$2.4 million in Q4 2025.
  • Historically, Interest Expenses has averaged $312812.5 across 5 years, with a median of $474000.0 in 2022.
  • Across the five-year window, Interest Expenses soared 411.11% in 2022 and slumped 569.11% in 2025, its largest moves.
  • Year by year, Interest Expenses stood at $428000.0 in 2022, then increased by 25.23% to $536000.0 in 2023, then decreased by 5.78% to $505000.0 in 2024, then slumped by 569.11% to -$2.4 million in 2025, then surged by 126.04% to $617000.0 in 2026.
  • Per Business Quant data, the three most recent Interest Expenses figures were $617000.0 in Q1 2026, -$2.4 million in Q4 2025, and $32000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -42,141.15
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 32.89 Mn
4 NuCana 279.75 Bn 279.75 Bn - 16.81 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.17 Bn
10 Savara 1.24 Bn 1.24 Bn - 617,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 617,000.00
Mar 31, 2026 617,000.00
Dec 31, 2025 -2.37 Mn
Dec 31, 2025 -2.37 Mn
Jun 30, 2025 32,000.00
Jun 30, 2025 32,000.00
Mar 31, 2025 1.33 Mn
Mar 31, 2025 1.33 Mn
Dec 31, 2024 505,000.00
Dec 31, 2024 505,000.00
Sep 30, 2024 281,000.00
Sep 30, 2024 281,000.00
Jun 30, 2024 309,000.00
Jun 30, 2024 309,000.00
Mar 31, 2024 536,000.00
Mar 31, 2024 536,000.00
Dec 31, 2023 536,000.00
Dec 31, 2023 536,000.00
Sep 30, 2023 394,000.00
Sep 30, 2023 394,000.00